Literature DB >> 33060967

Respiratory functional outcomes improvement with intervention in chronic empyema thoracis: a retrospective analysis.

Sanjeev Kumar1, Ashok Kumar1, Ajay Kumar Pal1, Suresh Kumar Ahirwar2, Suresh Kumar1, Arshad Ahmad1.   

Abstract

INTRODUCTION: Chronic pleural empyema is usually a consequence of in adequate treatment of acute pleural empyema. The incidence of tubercular and post-intervention empyema has increased in underdeveloped or developing countries adding to economic burden on the society. We have performed a retrospective analysis on role of intervention in chronic empyema to improve respiratory functional outcomes.
METHODS: We retrospectively reviewed data of 115 patients of chronic tubercular and parapneumonic empyema thoracis to evaluate change in functional outcome parameters based on their treatment modalities during follow-up in department of surgery, King George's Medical University, Lucknow, India. Accordingly, four groups were made-group 1 (tube thoracostomy), group 2 (decortication by video-assisted thoracoscopic surgery (VATS)), group 3 (decortication by open thoracotomy), and group 4 (window thoracostomy followed by thoracomyoplasty).
RESULTS: Significant improvement was noted in forced expiratory volume in one second (FEV1)% and forced vital capacity (FVC)% in all groups. In spirometry, percent change in mean FEV1 from pre-intervention to post-intervention was increase of 55.4%, 38.3%, 47.2, and 59.21% in group 1, group 2, group 3, and group 4 respectively, and percent change in mean FVC from pre-intervention to post-intervention was increase of 53.30%, 38.11%, 51.23, and 54.21% in group 1, group 2, group 3, and group 4 respectively.
CONCLUSION: Our study showed that a significant increase was observed in FVC and FEV1 from pre to post among all the groups. Comparable improvement of functional outcomes with non-operative intervention in properly selected patients can be achieved. © Indian Association of Cardiovascular-Thoracic Surgeons 2018.

Entities:  

Keywords:  Decortication; Empyema; Spirometry

Year:  2018        PMID: 33060967      PMCID: PMC7525645          DOI: 10.1007/s12055-018-0724-1

Source DB:  PubMed          Journal:  Indian J Thorac Cardiovasc Surg        ISSN: 0970-9134


  10 in total

Review 1.  Review of one hundred cases of empyema thoracis.

Authors:  S K Gupta; J Kishan; S P Singh
Journal:  Indian J Chest Dis Allied Sci       Date:  1989 Jan-Mar

2.  Clinical characteristics and outcomes of empyema thoracis in 117 patients: a comparative analysis of tuberculous vs. non-tuberculous aetiologies.

Authors:  P Malhotra; A N Aggarwal; R Agarwal; P Ray; D Gupta; S K Jindal
Journal:  Respir Med       Date:  2006-10-12       Impact factor: 3.415

3.  Empyema of the thorax.

Authors:  V K Jha; R B Singh
Journal:  Indian J Chest Dis       Date:  1972-10

4.  Pleural empyema. Changing etiologic, bacteriologic, and therapeutic aspects.

Authors:  A S Geha
Journal:  J Thorac Cardiovasc Surg       Date:  1971-04       Impact factor: 5.209

5.  Tubercular empyema thoracis: a diagnostic and therapeutic problem.

Authors:  T N Sharma; N K Jain; A Madan; S K Sarkar; P Durlabhji
Journal:  Indian J Chest Dis Allied Sci       Date:  1983 Apr-Jun

6.  Conservative management of empyema thoracis and broncho-pleural fistula.

Authors:  R P Singh; S K Katiyar; K P Singh
Journal:  Indian J Chest Dis Allied Sci       Date:  1994 Jan-Mar

7.  Empyema thoracis: a review of 70 cases.

Authors:  S K Agarwal; D C Roy; N Jha
Journal:  Indian J Chest Dis Allied Sci       Date:  1985 Jan-Mar

8.  Long-term functional results after surgical treatment of parapneumonic thoracic empyema.

Authors:  Christian Casali; Erica Susanna Storelli; Elena Di Prima; Uliano Morandi
Journal:  Interact Cardiovasc Thorac Surg       Date:  2009-04-14

9.  A study of empyema thoracis and role of intrapleural streptokinase in its management.

Authors:  Amit Banga; G C Khilnani; S K Sharma; A B Dey; Naveet Wig; Namrata Banga
Journal:  BMC Infect Dis       Date:  2004-06-29       Impact factor: 3.090

Review 10.  Use of DALYs in economic analyses on interventions for infectious diseases: a systematic review.

Authors:  A J J M Oostvogels; G A De Wit; B Jahn; A Cassini; E Colzani; C De Waure; M E E Kretzschmar; U Siebert; N Mühlberger; M-J J Mangen
Journal:  Epidemiol Infect       Date:  2014-12-12       Impact factor: 2.451

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.